HIND vs HOLX · rev $58.5K vs P/E 32, rev $4.10B
Vyome Holdings, Inc. (HIND) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
Vyome Holdings, Inc. (HIND) is a biotechnology company listed on NASDAQ.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Latest reported HIND revenue for 2026-06-30 was $58.5K. Net income was -$1.6M. Revenue was up 85.3% from 2026-03-31 to 2026-06-30. HIND currently screens at market cap $16.1M.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
HIND currently screens at market cap $16.1M. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the HIND and HOLX stock pages for the full models.
Not investment advice.